GE Healthcare

Physicians' Education Resource Announces 40th Annual Miami Breast Cancer Conference Scheduled for March 2-5, 2023

Retrieved on: 
Mercredi, février 8, 2023
GE Healthcare, Breast cancer, Fontainebleau Miami Beach, Exact sciences, Pfizer, Gilead Sciences, Conference, Radiation, AstraZeneca, Novartis, Health, Pharmaceutical industry

CRANBURY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Physicians' Education Resource®, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient care, today announced it will host its 40th Annual Miami Breast Cancer Conference® at the Fontainebleau Miami Beach, March 2-5, 2023.

Key Points: 
  • CRANBURY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Physicians' Education Resource®, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient care, today announced it will host its 40th Annual Miami Breast Cancer Conference® at the Fontainebleau Miami Beach, March 2-5, 2023.
  • This interactive, in-person-only conference will bring together surgical, medical and radiation oncologists to explore advanced strategies that have changed the landscape and expanded the arsenal of available breast cancer treatments.
  • This year, the Miami Breast Cancer Conference® will introduce a molecular tumor board session during the World-Class Tumor Board, radiation oncology and nursing tracks, and a poster walk with the program co-chairs and planning committee.
  • “Continuing that proud tradition, our 40th Annual Miami Breast Cancer Conference® is a testament to our longstanding commitment to meeting health care professionals’ educational needs with practice-focused knowledge and high-quality management strategies to improve patient outcomes.”
    To learn more about the conference, its credit designation and to register to attend, please visit the 40 th Annual Miami Breast Cancer Conference ® website .

AMC Health Announces Appointment of Chief Operating Officer

Retrieved on: 
Mardi, janvier 24, 2023
GE Healthcare, Diabetes, Chronic obstructive pulmonary disease, AMC, Philips, Caregiver, Lean Six Sigma, U.S. Department of Veterans Affairs, Office of Inspector General, Health, Head, Media in New York's Capital District, Depression, Patient, GE Power, FDA, Asthma, COPD, Business operations, Growth, Office of Inspector General, U.S. Department of Health and Human Services, Organization, Private equity, Heart failure, Management, Pharmaceutical industry

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- AMC Health today announced the appointment of James Considine as its new Chief Operating Officer, responsible for overseeing the company's business operations and translating AMC Health's strategic vision to drive continued growth and operating efficiency.

Key Points: 
  • NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- AMC Health today announced the appointment of James Considine as its new Chief Operating Officer, responsible for overseeing the company's business operations and translating AMC Health's strategic vision to drive continued growth and operating efficiency.
  • "I am excited and honored to take on the role of Chief Operating Officer for AMC Health," said Mr. Considine.
  • Zalmie Jacobs, Head of Private Equity at AMC Health investor York Capital and a member of AMC Health's board, added "AMC Health offers a market-leading solution to patients in need and is well positioned to transform the virtual care landscape.
  • I look forward to AMC Health benefiting from Mr. Considine's experience driving operational excellence across organizations."

GE HealthCare and Windsor Regional Hospital Enter Long-Term Innovative Technology Agreement

Retrieved on: 
Lundi, janvier 23, 2023
Diagnosis, Humber River Hospital, East Windsor Regional School District, Corporation, Ministry of Infrastructure (Ontario), Acquisition, MES, Health, GE Healthcare, Cardiology, Device file, GE, Patient, Google Images, National Health Laboratory Service, WRH, Maintenance, Hospital, Windsor-Essex Catholic District School Board

Windsor, ON, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Windsor Regional Hospital (WRH) and GE HealthCare (Nasdaq: GEHC) today announced a 15-year Managed Equipment Service (MES) agreement to deliver innovative technology solutions and services to the communities WRH serves to help enable better patient outcomes, improve efficiencies for clinicians and staff, and expected significant cost savings to the hospital for years to come.

Key Points: 
  • Windsor, ON, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Windsor Regional Hospital (WRH) and GE HealthCare (Nasdaq: GEHC) today announced a 15-year Managed Equipment Service (MES) agreement to deliver innovative technology solutions and services to the communities WRH serves to help enable better patient outcomes, improve efficiencies for clinicians and staff, and expected significant cost savings to the hospital for years to come.
  • This collaboration between GE HealthCare and the WRH clinical engineering team will provide system predictability and service resilience to help WRH deliver the future of healthcare.
  • “This agreement allows Windsor Regional Hospital to provide health services supported by leading edge medical equipment and technology to the residents of Windsor/Essex and all we serve,” says Malissa Gauthier, Windsor Regional Hospital Chief Financial Officer and Vice President, Corporate & Laboratory Services.
  • “GE HealthCare is here to serve the Windsor Regional community, predictably providing new and innovative technology to support their healthcare teams over the long-term,” says Mike Hamilton, President & CEO, GE HealthCare Canada.

A New-Era of Digital Health in Cardiac Monitoring has Begun Post Pandemic; Smart Wearables, AI-based ECG Becoming Integral Part of Ambulatory Cardiovascular Medical Practices; The Global Wearable ECG Devices Market to Witness Sales of $35 Billion by 2027

Retrieved on: 
Mardi, janvier 17, 2023
Medtronic, Digital, Boston Scientific, GE Healthcare, Baxter International, ECG, Holter monitor, SEER, Philips, Patient, Atrial fibrillation, Stroke, Biotelemetry, AF, Acquisition, Medical device

The region is the fastest-growing market for wearable ECG devices.

Key Points: 
  • The region is the fastest-growing market for wearable ECG devices.
  • North America offers tremendous opportunities for the players to boom in the market.
  • Moreover, the region is the single largest market for wearable ECG devices, thus becoming strategically important to many prominent market players such as GE Healthcare, Koninklijke Philips, and others.
  • There are many emerging companies trying to compete in the patch-based wearable ECG devices market segment.

A New-Era of Digital Health in Cardiac Monitoring has Begun Post Pandemic; Smart Wearables, AI-based ECG Becoming Integral Part of Ambulatory Cardiovascular Medical Practices; The Global Wearable ECG Devices Market to Witness Sales of $35 Billion by 2027

Retrieved on: 
Mardi, janvier 17, 2023
Medtronic, Digital, Boston Scientific, GE Healthcare, Baxter International, ECG, Holter monitor, SEER, Philips, Patient, Atrial fibrillation, Stroke, Biotelemetry, AF, Acquisition, Medical device

The region is the fastest-growing market for wearable ECG devices.

Key Points: 
  • The region is the fastest-growing market for wearable ECG devices.
  • North America offers tremendous opportunities for the players to boom in the market.
  • Moreover, the region is the single largest market for wearable ECG devices, thus becoming strategically important to many prominent market players such as GE Healthcare, Koninklijke Philips, and others.
  • There are many emerging companies trying to compete in the patch-based wearable ECG devices market segment.

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on: 
Mardi, janvier 17, 2023
National Association Medical Staff Services, Megasphaera, Honeywell, German Diabetes Center, World Health Organization, Kidney disease, DDZ, Temperature, National Center for Biotechnology Information, COVID-19, WHO, Blood pressure, GE Healthcare, Sinusitis, Health, Risk, Conditional sentence, Growth, Intel, National Center for Health Research, Prevalence, Diabetes, Masimo, Patient, Research, Cancer, Stroke, Kidney, Incidence, USD, Atherosclerosis, Pharmaceutical industry, Medtronic, Biotronik

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
  • The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
  • The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
  • Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on: 
Mardi, janvier 17, 2023
National Association Medical Staff Services, Megasphaera, Honeywell, German Diabetes Center, World Health Organization, Kidney disease, DDZ, Temperature, National Center for Biotechnology Information, COVID-19, WHO, Blood pressure, GE Healthcare, Sinusitis, Health, Risk, Conditional sentence, Growth, Intel, National Center for Health Research, Prevalence, Diabetes, Masimo, Patient, Research, Cancer, Stroke, Kidney, Incidence, USD, Atherosclerosis, Pharmaceutical industry, Medtronic, Biotronik

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
  • The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
  • The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
  • Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Global Intrauterine Insemination (IUI) Devices Markets, 2017-2022 & 2023-2027 - United States to Become a Lucrative Market Due to the Rise in Infertility Rates - ResearchAndMarkets.com

Retrieved on: 
Jeudi, janvier 19, 2023
Health, Genetics, Hospital, Catheter, Infertility, Polycystic disease, IUI, GE Healthcare, Artificial insemination, Uterus, AI, Fertilisation, Woman, PCOS, Growth, Patient, Automation, National Women's Health Network, United Nations, Femtech, ART, Life, Insemination, Union Council of Ministers, Fertility, Polycystic ovary syndrome, Erectile dysfunction, Birth control

The global intrauterine insemination (IUI) devices market is anticipated to observe impressive growth during the forecast period, 2023-2027.

Key Points: 
  • The global intrauterine insemination (IUI) devices market is anticipated to observe impressive growth during the forecast period, 2023-2027.
  • The major factors include rise in infertility rate, and advancements in healthcare facilities are driving the growth of the global intrauterine insemination (IUI) devices market.
  • This growing incidences of infertility among the world's population is propelling the Intrauterine Insemination (IUI) Devices market forward.
  • United States is expected to be a lucrative market in the forecast period due to rise in infertility rate in the country.

Global Population Health Management Market 2022 to 2031 - Featuring Allscripts Healthcare, Arcadia, Athenahealth and Citra Health Solutions Among Others - ResearchAndMarkets.com

Retrieved on: 
Mardi, janvier 17, 2023
Health, General Health, Benchmark, APM, Advisory board, Kantar Health, General Electric, Population Health Management, Accenture, Create, Cerner, McKesson Corporation, GE Healthcare, Epic Systems, Enli Health Intelligence, Organization, Population health, Orion Health, Growth, Patient, Software, Coronavirus, Research, IBM, General Electric Company, Renewable energy, Agriculture, Marketing, Healthcare

This report provides strategists, marketers and senior management with the critical information they need to assess the global population health management market.

Key Points: 
  • This report provides strategists, marketers and senior management with the critical information they need to assess the global population health management market.
  • The population health management market consists of sales of population health management solutions and related services by entities (organizations, sole proprietors, and partnerships) used to improve the health outcomes of a group by identifying and monitoring patients.
  • Major companies operating in population health management are looking for new product development to strengthen their position in the population health management market.
  • For instance, in October 2021, Verana Health, a US-based clinical database provider operating in the population health management market, launched VeraQ, a population health data engine.

Global Radiography Systems Market Analysis Report 2022: A $40 Billion Industry by 2028 - Size, Segments, Outlook, and Revenue Forecasts - ResearchAndMarkets.com

Retrieved on: 
Mardi, janvier 17, 2023
Health, Medical Devices, Technology, Health Technology, Other Technology, Other Health, Hardware, Product type, Joint, Cardiovascular disease, Swelling, Hospital, HRCT, Infection, Hospital Insurance and Diagnostic Services Act, COVID-19, Shimadzu, GE Healthcare, Agfa-Gevaert, Conditional sentence, Pregnancy, CT, Esaote, Osteoarthritis, Diagnosis, Patient, Prevalence, Diabetes, CT scan, Cancer, Canon Medical Systems Corporation, MRI, Spinal cord injury, Mammography, Carestream Health, General Electric Company, Network tomography, Pharmaceutical industry, Medical imaging, Unilab, Fujifilm

The "Global Radiography Systems Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Application, End User and Regions" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiography Systems Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Application, End User and Regions" report has been added to ResearchAndMarkets.com's offering.
  • According to this analysis, the Global Radiography Systems Market was valued at ~US$ 25 billion in 2017, it is estimated to be ~US$ 30 billion in 2022 and is expected to grow at a ~5% CAGR during 2022 to 2028, with market size of ~US$ 40 billion in 2028.
  • Increasing use of AI-enabled diagnostic equipment for rapid diagnosis and predictive analysis, notably in developed countries is one of the major contributing factors to the rising demand for radiography systems.
  • The ongoing COVID-19 pandemic has adversely affected the global radiography systems market in 2020, primarily due to a decline in patient visits to hospitals and clinics.